These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 20541152)

  • 21. Higher than expected prevalence of congenital cryptorchidism in Lithuania: a study of 1204 boys at birth and 1 year follow-up.
    Preiksa RT; Zilaitiene B; Matulevicius V; Skakkebaek NE; Petersen JH; Jørgensen N; Toppari J
    Hum Reprod; 2005 Jul; 20(7):1928-32. PubMed ID: 15860495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is testicular dysgenesis syndrome a genetic, endocrine, or environmental disease, or an unexplained reproductive disorder?
    Xing JS; Bai ZM
    Life Sci; 2018 Feb; 194():120-129. PubMed ID: 29183799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine disruptors and the male reproductive system.
    Stukenborg JB; Mitchell RT; Söder O
    Best Pract Res Clin Endocrinol Metab; 2021 Sep; 35(5):101567. PubMed ID: 34426080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recent trends in male reproductive disorders].
    Iwamoto T; Nozawa S
    Nihon Rinsho; 2000 Dec; 58(12):2514-20. PubMed ID: 11187747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible impact of phthalates on infant reproductive health.
    Lottrup G; Andersson AM; Leffers H; Mortensen GK; Toppari J; Skakkebaek NE; Main KM
    Int J Androl; 2006 Feb; 29(1):172-80; discussion 181-5. PubMed ID: 16466537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is new in cryptorchidism and hypospadias--a critical review on the testicular dysgenesis hypothesis.
    Thorup J; McLachlan R; Cortes D; Nation TR; Balic A; Southwell BR; Hutson JM
    J Pediatr Surg; 2010 Oct; 45(10):2074-86. PubMed ID: 20920735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethnic patterns of hypospadias in New Zealand do not resemble those observed for cryptorchidism and testicular cancer: evidence of differential aetiology?
    Gurney JK; Stanley J; Shaw C; Sarfati D
    Andrology; 2016 Jan; 4(1):82-6. PubMed ID: 26566182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International geographic correlation study of the prevalence of disorders of male reproductive health.
    Serrano T; Chevrier C; Multigner L; Cordier S; Jégou B
    Hum Reprod; 2013 Jul; 28(7):1974-86. PubMed ID: 23670171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocrine Disrupting Chemicals and Reproductive Health in Boys and Men.
    Rodprasert W; Toppari J; Virtanen HE
    Front Endocrinol (Lausanne); 2021; 12():706532. PubMed ID: 34690925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shorter anogenital distance correlates with undescended testis: a detailed genital anthropometric analysis in human newborns.
    Jain VG; Singal AK
    Hum Reprod; 2013 Sep; 28(9):2343-9. PubMed ID: 23838161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal decline of sperm concentration: role of endocrine disruptors.
    Cannarella R; Gül M; Rambhatla A; Agarwal A
    Endocrine; 2023 Jan; 79(1):1-16. PubMed ID: 36194343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproductive dysgenesis in wildlife: a comparative view.
    Edwards TM; Moore BC; Guillette LJ
    Int J Androl; 2006 Feb; 29(1):109-21. PubMed ID: 16466531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of micropenis in 2710 male newborns from an intensive-use pesticide area of Northeastern Brazil.
    Gaspari L; Sampaio DR; Paris F; Audran F; Orsini M; Neto JB; Sultan C
    Int J Androl; 2012 Jun; 35(3):253-64. PubMed ID: 22372605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testicular dysgenesis syndrome comprises some but not all cases of hypospadias and impaired spermatogenesis.
    Jørgensen N; Rajpert-De Meyts E; Main KM; Skakkebaek NE
    Int J Androl; 2010 Apr; 33(2):298-303. PubMed ID: 20132348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The epidemiology of cryptorchidism and potential risk factors, including endocrine disrupting chemicals.
    Holmboe SA; Beck AL; Andersson AM; Main KM; Jørgensen N; Skakkebæk NE; Priskorn L
    Front Endocrinol (Lausanne); 2024; 15():1343887. PubMed ID: 38633762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testicular dysgenesis syndrome.
    Skakkebaek NE
    Horm Res; 2003; 60 Suppl 3():49. PubMed ID: 14671395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Male Reproductive System and Endocrine Disruptors.
    Schiesaro MG; Amato AML; Maneschi C; Sciabica V; Pigatto E; Sanna M
    Endocr Metab Immune Disord Drug Targets; 2022 Aug; 22(7):686-703. PubMed ID: 34607552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Environmental Impacts on Male Reproductive Development: Lessons from Experimental Models.
    Jorgensen A; Svingen T; Miles H; Chetty T; Stukenborg JB; Mitchell RT
    Horm Res Paediatr; 2023; 96(2):190-206. PubMed ID: 34607330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine disruption and male reproductive disorders: unanswered questions.
    Sharpe RM
    Hum Reprod; 2024 Sep; 39(9):1879-1888. PubMed ID: 38926156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Environment, testicular dysgenesis and carcinoma in situ testis.
    Olesen IA; Sonne SB; Hoei-Hansen CE; Rajpert-De Meyts E; Skakkebaek NE
    Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):462-78. PubMed ID: 17875492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.